290 related articles for article (PubMed ID: 35142156)
41. Identification and functional characterization of a novel 27-bp deletion in the macroglycopeptide-coding region of the GPIBA gene resulting in platelet-type von Willebrand disease.
Othman M; Notley C; Lavender FL; White H; Byrne CD; Lillicrap D; O'Shaughnessy DF
Blood; 2005 Jun; 105(11):4330-6. PubMed ID: 15705799
[TBL] [Abstract][Full Text] [Related]
42. Variability in platelet- and collagen-binding defects in type 2M von Willebrand disease.
Larsen DM; Haberichter SL; Gill JC; Shapiro AD; Flood VH
Haemophilia; 2013 Jul; 19(4):590-4. PubMed ID: 23496210
[TBL] [Abstract][Full Text] [Related]
43. Post-DDAVP thrombocytopenia in type 2B von Willebrand disease is not associated with platelet consumption: failure to demonstrate glycocalicin increase or platelet activation.
Casonato A; Steffan A; Pontara E; Zucchetto A; Rossi C; De Marco L; Girolami A
Thromb Haemost; 1999 Feb; 81(2):224-8. PubMed ID: 10063996
[TBL] [Abstract][Full Text] [Related]
44. Laboratory diagnosis and molecular classification of von Willebrand disease.
Gadisseur A; Hermans C; Berneman Z; Schroyens W; Deckmyn H; Michiels JJ
Acta Haematol; 2009; 121(2-3):71-84. PubMed ID: 19506352
[TBL] [Abstract][Full Text] [Related]
45. Measurement of von Willebrand factor binding to a recombinant fragment of glycoprotein Ibalpha in an enzyme-linked immunosorbent assay-based method: performances in patients with type 2B von Willebrand disease.
Caron C; Hilbert L; Vanhoorelbeke K; Deckmyn H; Goudemand J; Mazurier C
Br J Haematol; 2006 Jun; 133(6):655-63. PubMed ID: 16704443
[TBL] [Abstract][Full Text] [Related]
46. A new mutation, S1285F, within the A1 loop of von Willebrand factor induces a conformational change in A1 loop with abnormal binding to platelet GPIb and botrocetin causing type 2M von Willebrand disease.
Stepanian A; Ribba AS; Lavergne JM; Fressinaud E; Juhan-Vague I; Mazurier C; Girma JP; Meyer D
Br J Haematol; 2003 Feb; 120(4):643-51. PubMed ID: 12588351
[TBL] [Abstract][Full Text] [Related]
47. GPIbα-vWF rolling under shear stress shows differences between type 2B and 2M von Willebrand disease.
Coburn LA; Damaraju VS; Dozic S; Eskin SG; Cruz MA; McIntire LV
Biophys J; 2011 Jan; 100(2):304-12. PubMed ID: 21244826
[TBL] [Abstract][Full Text] [Related]
48. A family having type 2B von Willebrand disease with an R1306W mutation: Severe thrombocytopenia leads to the normalization of high molecular weight multimers.
Ozeki M; Kunishima S; Kasahara K; Funato M; Teramoto T; Kaneko H; Fukao T; Kondo N
Thromb Res; 2010 Feb; 125(2):e17-22. PubMed ID: 19740526
[TBL] [Abstract][Full Text] [Related]
49. Enhanced Local Disorder in a Clinically Elusive von Willebrand Factor Provokes High-Affinity Platelet Clumping.
Tischer A; Machha VR; Frontroth JP; Brehm MA; Obser T; Schneppenheim R; Mayne L; Walter Englander S; Auton M
J Mol Biol; 2017 Jul; 429(14):2161-2177. PubMed ID: 28533135
[TBL] [Abstract][Full Text] [Related]
50. von Willebrand disease type 2A phenotypes IIC, IID and IIE: A day in the life of shear-stressed mutant von Willebrand factor.
Brehm MA; Huck V; Aponte-Santamaría C; Obser T; Grässle S; Oyen F; Budde U; Schneppenheim S; Baldauf C; Gräter F; Schneider SW; Schneppenheim R
Thromb Haemost; 2014 Jul; 112(1):96-108. PubMed ID: 24598842
[TBL] [Abstract][Full Text] [Related]
51. Platelet-type von Willebrand disease: a rare, often misdiagnosed and underdiagnosed bleeding disorder.
Othman M
Semin Thromb Hemost; 2011 Jul; 37(5):464-9. PubMed ID: 22102188
[TBL] [Abstract][Full Text] [Related]
52. LIM kinase/cofilin dysregulation promotes macrothrombocytopenia in severe von Willebrand disease-type 2B.
Kauskot A; Poirault-Chassac S; Adam F; Muczynski V; Aymé G; Casari C; Bordet JC; Soukaseum C; Rothschild C; Proulle V; Pietrzyk-Nivau A; Berrou E; Christophe OD; Rosa JP; Lenting PJ; Bryckaert M; Denis CV; Baruch D
JCI Insight; 2016 Oct; 1(16):e88643. PubMed ID: 27734030
[TBL] [Abstract][Full Text] [Related]
53. Functional studies on platelet adhesion with recombinant von Willebrand factor type 2B mutants R543Q and R543W under conditions of flow.
Lankhof H; Damas C; Schiphorst ME; IJsseldijk MJ; Bracke M; Sixma JJ; Vink T; de Groot PG
Blood; 1997 Apr; 89(8):2766-72. PubMed ID: 9108394
[TBL] [Abstract][Full Text] [Related]
54. Gain-of-function GPIb ELISA assay for VWF activity in the Zimmerman Program for the Molecular and Clinical Biology of VWD.
Flood VH; Gill JC; Morateck PA; Christopherson PA; Friedman KD; Haberichter SL; Hoffmann RG; Montgomery RR
Blood; 2011 Feb; 117(6):e67-74. PubMed ID: 21148813
[TBL] [Abstract][Full Text] [Related]
55. Platelet-type von Willebrand disease: new insights into the molecular pathophysiology of a unique platelet defect.
Othman M; Kaur H; Emsley J
Semin Thromb Hemost; 2013 Sep; 39(6):663-73. PubMed ID: 23934752
[TBL] [Abstract][Full Text] [Related]
56. Crystal structure of the wild-type von Willebrand factor A1-glycoprotein Ibalpha complex reveals conformation differences with a complex bearing von Willebrand disease mutations.
Dumas JJ; Kumar R; McDonagh T; Sullivan F; Stahl ML; Somers WS; Mosyak L
J Biol Chem; 2004 May; 279(22):23327-34. PubMed ID: 15039442
[TBL] [Abstract][Full Text] [Related]
57. Apoptotic Platelet Events Are Not Observed in Severe von Willebrand Disease-Type 2B Mutation p.V1316M.
Berrou E; Kauskot A; Adam F; Harel A; Legendre P; Lavenu Bombled C; Rothschild C; Prevost N; Christophe OD; Lenting PJ; Denis CV; Rosa JP; Bryckaert M
PLoS One; 2015; 10(12):e0143896. PubMed ID: 26645283
[TBL] [Abstract][Full Text] [Related]
58. Molecular modeling of ligand and mutation sites of the type A domains of human von Willebrand factor and their relevance to von Willebrand's disease.
Jenkins PV; Pasi KJ; Perkins SJ
Blood; 1998 Mar; 91(6):2032-44. PubMed ID: 9490688
[TBL] [Abstract][Full Text] [Related]
59. Laboratory diagnosis of von Willebrand disease type 1/2E (2A subtype IIE), type 1 Vicenza and mild type 1 caused by mutations in the D3, D4, B1-B3 and C1-C2 domains of the von Willebrand factor gene. Role of von Willebrand factor multimers and the von Willebrand factor propeptide/antigen ratio.
Gadisseur A; Berneman Z; Schroyens W; Michiels JJ
Acta Haematol; 2009; 121(2-3):128-38. PubMed ID: 19506359
[TBL] [Abstract][Full Text] [Related]
60. N1421K mutation in the glycoprotein Ib binding domain impairs ristocetin- and botrocetin-mediated binding of von Willebrand factor to platelets.
Lanke E; Kristoffersson AC; Isaksson C; Holmberg L; Lethagen S
Eur J Haematol; 2008 Nov; 81(5):384-90. PubMed ID: 18637125
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]